Glycosphingolipids as emerging attack points in bladder cancer.

Area of Science:

• Oncology
• Glycobiology
• Cancer Research

Background:

• Bladder cancer presents a significant global health challenge with high morbidity and mortality.
• Glycosphingolipids (GSLs) are increasingly recognized for their crucial role in the development and progression of bladder cancer.

Purpose of the Study:

• To review the expression patterns of GSLs in bladder cancer.
• To elucidate the contribution of GSLs to cancer hallmarks such as invasion, metastasis, immune evasion, and apoptosis resistance.
• To explore the therapeutic potential of GSLs and their utility as non-invasive biomarkers.

Main Methods:

• Comprehensive literature review of GSL expression in bladder cancer.
• Analysis of GSL involvement in key cancer hallmarks.
• Evaluation of GSL-targeting strategies and biomarker development, including novel glyco-analytical technologies.

Main Results:

• GSL expression profiles are altered in bladder cancer, correlating with disease progression.
• GSLs significantly contribute to bladder cancer's invasive and metastatic capabilities, immune evasion mechanisms, and resistance to programmed cell death.
• Recent advances demonstrate the potential of GSLs as therapeutic targets and non-invasive biomarkers, with a novel patented biomarker identified.

Conclusions:

• GSLs play a multifaceted role in bladder cancer progression and are promising targets for novel therapeutic interventions.
• The identified novel biomarker, discovered using advanced glyco-analytical techniques, shows potential for improved bladder cancer diagnosis.
• Further research into GSLs can lead to more effective diagnostic and therapeutic strategies for bladder cancer.